Finerenone, a Non-Steroidal Mineralocorticoid Receptor Antagonist, Reduces Vascular Injury and Increases Regulatory T-Cells: Studies in Rodents with Diabetic and Neovascular Retinopathy
Jack R. Jerome(Translational Research Institute), Jennifer L. Wilkinson‐Berka(The University of Melbourne)
Cited by 32
Related Papers
Nrf2 Activation Is a Potential Therapeutic Approach to Attenuate Diabetic Retinopathy
|Investigative Ophthalmology & Visual Science|2018|72
Early Depletion of Neutrophils Reduces Retinal Inflammation and Neovascularization in Mice with Oxygen-Induced Retinopathy
|International Journal of Molecular Sciences|2023|19
Alpha-1 antitrypsin reduces inflammation and vasculopathy in mice with oxygen-induced retinopathy
|Journal of Inflammation|2025|1